Shenzhen Hepalink Pharmaceutical Co Ltd (002399) — Free Cash Flow Generation Index
Shenzhen Hepalink Pharmaceutical Co Ltd (002399) has a Free Cash Flow Generation Index of 0.97x as of September 2025. Free cash flow of CN¥385.83 Million represents 1% of operating cash flow (CN¥399.43 Million). Read Shenzhen Hepalink Pharmaceutical Co Ltd balance sheet liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Shenzhen Hepalink Pharmaceutical Co Ltd Free Cash Flow Generation Index (2006–2025)
Historical FCF Generation Index trend for Shenzhen Hepalink Pharmaceutical Co Ltd across 16 annual periods. Explore capital reinvestment ratio of Shenzhen Hepalink Pharmaceutical Co Ltd to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Shenzhen Hepalink Pharmaceutical Co Ltd (2006–2025)
Year-by-year Free Cash Flow Generation Index for Shenzhen Hepalink Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see 002399 market cap.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.93x | CN¥1.59 Billion | CN¥1.71 Billion | CN¥121.10 Million | ▲ +2.4% |
| 2024 | 0.91x | CN¥1.99 Billion | CN¥2.19 Billion | CN¥202.77 Million | ▲ +874.5% |
| 2023 | -0.12x | CN¥-46.66 Million | CN¥398.22 Million | CN¥444.88 Million | ▲ +97.5% |
| 2020 | -4.70x | CN¥-175.21 Million | CN¥37.28 Million | CN¥212.49 Million | ▼ -2462.3% |
| 2018 | 0.20x | CN¥132.86 Million | CN¥667.87 Million | CN¥535.01 Million | ▲ +611.3% |
| 2016 | -0.04x | CN¥-13.46 Million | CN¥346.07 Million | CN¥359.54 Million | ▼ -104.8% |
| 2015 | 0.81x | CN¥724.86 Million | CN¥893.71 Million | CN¥168.85 Million | ▼ -0.6% |
| 2014 | 0.82x | CN¥745.18 Million | CN¥912.80 Million | CN¥167.62 Million | ▲ +170.6% |
| 2013 | 0.30x | CN¥126.99 Million | CN¥420.97 Million | CN¥293.98 Million | ▼ -39.5% |
| 2012 | 0.50x | CN¥236.34 Million | CN¥473.89 Million | CN¥237.55 Million | ▼ -44.9% |
| 2011 | 0.90x | CN¥1.27 Billion | CN¥1.41 Billion | CN¥134.16 Million | ▲ +0.6% |
| 2010 | 0.90x | CN¥318.93 Million | CN¥354.86 Million | CN¥35.93 Million | ▲ +6.3% |
| 2009 | 0.85x | CN¥300.89 Million | CN¥355.81 Million | CN¥54.91 Million | ▲ +15.8% |
| 2008 | 0.73x | CN¥29.32 Million | CN¥40.13 Million | CN¥10.81 Million | ▲ +433.6% |
| 2007 | 0.14x | CN¥1.90 Million | CN¥13.85 Million | CN¥11.95 Million | ▼ -83.9% |
| 2006 | 0.85x | CN¥60.95 Million | CN¥71.66 Million | CN¥10.71 Million | — |